BioPharma Resources

Investigational drug · Phase 3

CM336

Also called: group, QiShen YiQi Dripping Pills 3 bags

Not approved by FDA. In 7 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Multiple Myeloma (MM), Primary Light-Chain Amyloidosis, Primary Immune Thrombocytopenia.

Phase 3

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

7

5 still active

All registered trials

20

Any phase or sponsor naming "CM336"

First trial start

2021

Jul 13, 2021

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "CM336", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Multiple Myeloma (MM)
  • Primary Light-Chain Amyloidosis
  • Primary Immune Thrombocytopenia
  • Autoimmune Cytopenia
  • Immune Thrombocytopenia (ITP)
  • Autoimmune Hemolytic Anemia
  • Evans Syndrome
  • Diabetic Kidney Disease
  • Chronic Heart Failure With Reduced Ejection Fraction

Approved drugs for the same conditions: Heart failure · Multiple myeloma · Anemia · Immune thrombocytopenia · Hematology and blood cancers · Cardiovascular and metabolic · Rare and genetic disease · Kidney and urology

Largest trials

Live from ClinicalTrials.gov: studies naming "CM336" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 3,853,804 on PubMed

Also in development for Multiple Myeloma (MM)

  • GR1803Velinotamig specified specified days., CLN-803Phase 37 trials

    Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Multiple Myeloma, Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA)

  • CM313Phase 36 trials

    Keymed Biosciences Co.Ltd · Systemic Lupus Erythematosus, Primary Immune Thrombocytopenia, Platelet Transfusion Refractoriness

  • SCTC21CPhase 34 trials

    Sinocelltech Ltd. · IgA Nephropathy, Multiple Myeloma (MM), Systemic Lupus Erythematosus (SLE)

  • IDP-121Phase 22 trials

    IDP Discovery Pharma S.L. · Small Cell Lung Cancer ( SCLC ), Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

  • BT02Phase 21 trial

    Biotroy Therapeutics · Relapsed or Refractory Hematologic Malignancies, Leukemia, Lymphoma

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.